Supernus Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SUPN and other ETFs, options, and stocks.

About SUPN

Supernus Pharmaceuticals, Inc. engages in the development and commercialization of products for the treatment of central nervous system diseases. It offers Trokendi XR, Oxtellar XR, APOKYN, XADAGO, and MYOBLOC products. 

CEO
Jack A. Khattar
CEOJack A. Khattar
Employees
778
Employees778
Headquarters
Rockville, Maryland
HeadquartersRockville, Maryland
Founded
2005
Founded2005
Employees
778
Employees778

SUPN Key Statistics

Market cap
2.21B
Market cap2.21B
Price-Earnings ratio
-20.67
Price-Earnings ratio-20.67
Dividend yield
—
Dividend yield—
Average volume
870.68K
Average volume870.68K
High today
$39.52
High today$39.52
Low today
$37.54
Low today$37.54
Open price
$39.19
Open price$39.19
Volume
1.04M
Volume1.04M
52 Week high
$59.68
52 Week high$59.68
52 Week low
$37.54
52 Week low$37.54

Stock Snapshot

The current Supernus Pharmaceuticals(SUPN) stock price is $37.96, with a market capitalization of 2.21B. The stock trades at a price-to-earnings (P/E) ratio of -20.67.

During the trading session on 2026-10-16, Supernus Pharmaceuticals(SUPN) shares reached a daily high of $39.52 and a low of $37.54. At a current price of $37.96, the stock is +1.1% higher than the low and still -4.0% under the high.

Trading volume for Supernus Pharmaceuticals(SUPN) stock has reached 1.04M, versus its average volume of 870.68K.

The stock's 52-week range extends from a low of $37.54 to a high of $59.68.

The stock's 52-week range extends from a low of $37.54 to a high of $59.68.

SUPN News

Simply Wall St 22h
Is Supernus Pharmaceuticals Still Worth A Look After Its Valuation Reset? - Simply Wall Street

...

Is Supernus Pharmaceuticals Still Worth A Look After Its Valuation Reset? - Simply Wall Street
TipRanks 23h
Supernus Stockholders Approve Merger with Indivior Pharmaceuticals

Supernus Pharmaceuticals ( (SUPN) ) has issued an announcement. On October 15, 2026, Supernus Pharmaceuticals held a special meeting of stockholders to vote on...

People also own

Based on the portfolios of people who own SUPN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.